Navigation Links
Yongye Biotechnology International Announces Second Quarter Results
Date:8/18/2008

BEIJING, Aug. 18 /Xinhua-PRNewswire-FirstCall/ -- Yongye Biotechnology International, Inc. (OTC Bulletin Board: YGYB) ("Yongye" or the "Company"), a leading developer, producer and distributor of nutrients for plants and animals in the People's Republic of China, today announced its financial results for the quarter ended June 30, 2008.

Second Quarter 2008 Highlights

-- Revenue was $17.6 million, an increase of 136.6% from the second

quarter of 2007, and an increase of 87.0% from the first quarter of

2008

-- Gross profit was $9.6 million, a 171.8% increase from the second

quarter of 2007, with a gross margin of 54.5%

-- Net income was $7.2 million, an increase of 116.2% from the second

quarter of 2007, or $0.41 per diluted share

-- Completed a share exchange transaction to become a publicly traded

company in April 2008

-- Raised $10.0 million gross proceeds through a private placement

financing in April 2008

Second Quarter 2008 Financial Results

"The second quarter of the year is typically our strongest quarter for sales of plant and animal nutrient products, and this year's second quarter had exceptionally good results, with both revenue and earnings more than doubling from the prior year period," said Mr. Zishen Wu, Chief Executive Officer of Yongye. "We attribute this to the very strong benefits our customers are able to gain from the use of our technologically advanced products and the rapid expansion of our distribution network to cover new geographic regions and build strong brand recognition for our products."

Second Quarter 2008 Results

Revenue was $17.6 million in the second quarter of 2008, an increase of 136.6% from $7.4 million in the second quarter of 2007. This significant revenue increase was due mainly to the rapid expansion of the Company's sales network. An additional 425 branded stores were added to the distribution n
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
2. Yongye Biotechnology International Retains CCG Investor Relations
3. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
4. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
5. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
6. New Book on the Business of Biotechnology
7. InNexus Biotechnology CEO and Chief Scientific Officer to Present at IBCs Annual World Congress Conference in Boston on Aug 6th
8. Champions Biotechnology Reports Fiscal 2008 Full-Year Financial Results
9. Athera Biotechnology Founder Johan Frostegard and His Colleagues Win NACB Distinguished Abstract Award at AACC 2008
10. Pennsylvania Governor Rendell Says State Number 1 in New Biotechnology Study
11. WuXi PharmaTech (NYSE: WX) Wins the 2008 Frost & Sullivan Award for Best in Class Outsourced R&D in Pharmaceuticals and Biotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  CorMedix Inc. ... developing and commercializing therapeutic products for the prevention ... announces receipt of notice on July 18, 2014 ... NYSE-MKT has accepted the CorMedix plan to regain ... As a result, the NYSE-MKT is continuing the ...
(Date:7/24/2014)... 2014 2014 Deep Research Report ... a professional and in-depth research report on Potassium ... basic information, including its definition, classification, application, ... research covers the international market analysis, including China’s ... covering macroeconomic environment & economic situation analysis, the ...
(Date:7/24/2014)... July 24, 2014 WIRB-Copernicus Group ® ... and ethical review services for clinical research, announced ... a division of Richmond, VA ... biosafety and biosecurity consulting firm in ... WCG,s biosafety division – WCG Biosafety™ – will ...
(Date:7/24/2014)... The first part of the session on “Best ... Studies” will cover comprehensive clinical support in early phase ... R&D costs and declining industry success in getting products ... collected in early Phase I/IIa study data to make ... development. , Next, the presenters will examine steps to ...
Breaking Biology Technology:CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 2Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 3Potassium Sulphate Market & SHMP Industry 2014 (Global, China) Analysis Now Available at DeepResearchReports.com 4WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Best Practices for Optimizing Dose Escalation in First in Human Studies, New Webinar August 6th Hosted by Xtalks 2
... 2010 Sequenom, Inc. (Nasdaq: SQNM ... describing results from the R&D "locked-assay" verification study ... for Molecular Medicine. (Logo:   ... entitled "Noninvasive Detection of Fetal Trisomy 21 by ...
... 2010 Dr. Russell L. Chapman, former President of ... the research and teaching of algal related science in ... Chairman of its Science Advisory Board including university outreach, ... one of the preeminent scholars in the field of ...
... Dec. 15, 2010 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. ("China-Biotics" or ... developer, manufacturer and distributor of probiotics products in China, ... Stockholders (the "Annual Meeting") will be held on Wednesday, ... Annual Meeting will be held at the Company,s executive ...
Cached Biology Technology:Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study 2Sequenom Announces Publication Acceptance of Manuscript From Trisomy 21 R&D Verification Study 3Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 2Dr. Russell L. Chapman Joins Aquatic Energy as the Chairman of its Science Advisory Board 3China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011 2China-Biotics, Inc. to Hold 2010 Annual Meeting of Stockholders on March 9, 2011 3
(Date:7/24/2014)... animal species for food or commercial food sale, has ... the decline of many species of primates and other ... than half of the species being consumed are birds, ... not only the meat made available for sale but ... by hunters and brought to villages for consumption, we ...
(Date:7/24/2014)... where electric cars ply silent freeways, solar panels blanket ... the earth, from howling winds and from the blazing ... it is technically and economically feasible to convert California,s ... energy. Published in Energy , the plan shows ... supply in California that could create tens of thousands ...
(Date:7/24/2014)... of researchers has developed a new nanoscale agent for ... for assessing the function and properties of the GI ... and treatment of gut diseases. , Illnesses ... and inflammatory bowel disease all occur in the intestine ... with diseases such as diabetes and Parkinson,s. , ...
Breaking Biology News(10 mins):Stanford study shows how to power California with wind, water and sun 2Stanford study shows how to power California with wind, water and sun 3Stanford study shows how to power California with wind, water and sun 4New imaging agent provides better picture of the gut 2
... The evolution of bird bills is related to climate according ... Brock University, Canada. By examining bill sizes of a ... found that birds with larger bills tend to be found ... smaller bills. The study led by Dr Matt Symonds ...
... , In what is believed to be the largest review of ... are more likely to clump faster than others, scientists at Johns ... which they say likely control that bodily function. "Our results ... produced from these genes, to develop tests that could help us ...
... The American Association for Cancer Research recognizes the first ... Act, which was signed into law by President Obama ... the Food and Drug Administration (FDA) to regulate the ... go into effect today include restrictions on youth access ...
Cached Biology News:Birds reduce their heating bills in cold climates 2Genetic septet in control of blood platelet clotting 2Genetic septet in control of blood platelet clotting 3AACR recognizes 1-year anniversary of tobacco law 2
... ESGRO Complete Derivation Kit is intended ... cells from delayed blastocysts in serum-free ... Clonal Grade ... Blastocyst Incubation Medium Trypsin Solution ...
streptavidin, Alexa Fluor® 750–allophycocyanin conjugate (Alexa Fluor® 750–allophycocyanin streptavidin) *1 mg/mL*...
Template and primers for preparation of internal control spots...
Biotin-OSu is used to label proteins, immunological agents, DNA and synthetic oligonucleotides. Biotin labeling is detected through enzymatically labeled avidin or streptavidin proteins that conforma...
Biology Products: